Videos de Experimentos Relacionados
Resumen
Las variantes del ADN mitocondrial pueden causar enfermedades humanas, especialmente trastornos de la sangre relacionados con el cloramfenicol. Estas condiciones, heredadas por la madre, aparecen en individuos relacionados y dependen de la distribución mitocondrial durante el desarrollo.
Videos de Conceptos Relacionados
También podría leer
Artículos Relacionados
Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.
Ordenar por
Same author
Mixture analysis of tuberculin survey data from northern Malawi and critique of the method.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2006
Same author
Comparison of two versus three smears in identifying culture-positive tuberculosis patients in a rural African setting with high HIV prevalence.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2001
Same author
Field-based random sampling without a sampling frame: control selection for a case-control study in rural Africa.
Transactions of the Royal Society of Tropical Medicine and Hygiene·2001
Same author
The development of the HIV epidemic in Karonga District, Malawi.
AIDS (London, England)·2001
Same author
Environmental mycobacteria in northern Malawi: implications for the epidemiology of tuberculosis and leprosy.
Epidemiology and infection·2001
Same journal
Assisted dying and the silencing of medicine's next generation.
Lancet (London, England)·2026
Same journal
Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.
Lancet (London, England)·2026
Same journal
Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.
Lancet (London, England)·2026
Same journal
[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.
Lancet (London, England)·2026
Same journal
Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.
Lancet (London, England)·2026